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VIIP 2017 CLINICAL UPDATE 
INTRODUCTION: NASA’s Space Medicine community knowledge regarding the “Vision 
Impairment Intracranial Pressure”, or VIIP.has been evolving over time.  .  Various measures of 
occupational health related to this condition had to be determined and then plans/processes put 
into place.  The most robust of these processes were inititated in 2010.  This presentation will 
provide a clinic update of the astronaut occupational health data related to VIIP. 
METHODS: NASA and its international partners require its astronauts to undergo routine health 
measures deemed important to monitoring VIIP.  The concern is that the spaceflight environment 
aboard ISS could cause some astronauts to have physiologic changes detrimental to either ongoing 
mission operations or long-term health related to the ocular system and possibly the CNS.  Specific 
medical tests include but are not limited to brain/orbit MRI (NASA unique protocol), OCT, 
fundoscopy and ocular ultrasound.  Measures are taken prior to spaceflight, in-flight and post-flight.  
Measures to be reported include incidence of disc edema, globe flattening, choroidal folds, ONSD 
and change in refractive error. 
RESULTS: 73 ISS astronauts have been evaluated at least partially for VIIP related measures.  Of 
these individuals, approximately 1 in 7 have experienced disc edema.  The prevalence of the other 
findings is more complicated as the medical testing has changed over time.    Overall, 26 separate 
individuals have experienced at least one of the findings NASA has associated with VIIP Another 
confounding factor is most of the astronauts have prior spaceflight experience at the time of the 
“pre-flight” testing.   
DISCUSSION: In 2010 NASA and its US operating segment (USOS) partners (CSA, ESA and 
JAXA) began routine occupational monitoring and data collection for most VIIP related changes.    
Interpretation of that data is extremely challenging for several reasons.  For example, the 
determination of disc edema is the most complete finding  as we have had highly qualified 
optometrists routinely and competently performing post-flight funduscopic exams for the entirety of 
the ISS program.  Yet in 2013 NASA added OCT to our in-flight suite of eye exams.  Shortly after 
routine screening with the OCT, a new term appeared within VIIP vernacular – “subclinical disc 
edema”.  OCT has much greater ability to measure change within the retina and provides 
significantly more data to analyze, understand and communicate out. 
Communicating VIIP data clearly adds even more challenge.  Historically we’ve reported data per 
eye and not necessarily per person.  This has led to difficulty in understanding how many individuals 
have experienced “VIIP” within the aerospace medicine community.  The presenter will attempt to 
provide clear and concise communication of VIIP findings. 
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